Associated Papers
Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment.
Song Y et al.
Journal for Immunotherapy of Cancer, 2023
37777251 (PubMed )
Supplement: jitc-2022-006643supp001.pdf
Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment.
Li J et al.
Aging, 2021
34160364 (PubMed )
Supplement: aging-13-203175-s003.xlsx › ___1
Heterozygous mutations in ERF cause syndromic craniosynostosis with multiple suture involvement.
Chaudhry A et al.
American Journal of Medical Genetics. Part A, 2015
Select a paper to view details